667 related articles for article (PubMed ID: 9686582)
21. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
[TBL] [Abstract][Full Text] [Related]
22. Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones.
Anel A; Simon AK; Auphan N; Buferne M; Boyer C; Golstein P; Schmitt-Verhulst AM
Eur J Immunol; 1995 Dec; 25(12):3381-7. PubMed ID: 8566027
[TBL] [Abstract][Full Text] [Related]
23. Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions.
Bergmann-Leitner ES; Abrams SI
Cell Immunol; 2001 Apr; 209(1):49-62. PubMed ID: 11414736
[TBL] [Abstract][Full Text] [Related]
24. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
[TBL] [Abstract][Full Text] [Related]
25. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
[TBL] [Abstract][Full Text] [Related]
26. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
Oyaizu N; Adachi Y; Hashimoto F; McCloskey TW; Hosaka N; Kayagaki N; Yagita H; Pahwa S
J Immunol; 1997 Mar; 158(5):2456-63. PubMed ID: 9036997
[TBL] [Abstract][Full Text] [Related]
27. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
[TBL] [Abstract][Full Text] [Related]
28. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
Pandolfino MC; Viret C; Gervois N; Guilloux Y; Davodeau F; Diez E; Jotereau F
Eur J Immunol; 1992 Jul; 22(7):1795-802. PubMed ID: 1623924
[TBL] [Abstract][Full Text] [Related]
29. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
[TBL] [Abstract][Full Text] [Related]
30. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
Kessler B; Hudrisier D; Schroeter M; Tschopp J; Cerottini JC; Luescher IF
J Immunol; 1998 Dec; 161(12):6939-46. PubMed ID: 9862728
[TBL] [Abstract][Full Text] [Related]
31. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.
Singh RK; Varney ML; Buyukberber S; Ino K; Ageitos AG; Reed E; Tarantolo S; Talmadge JE
Cancer Res; 1999 Jul; 59(13):3107-11. PubMed ID: 10397252
[TBL] [Abstract][Full Text] [Related]
32. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporine-insensitive partial signaling and multiple roles of Ca2+ in Fas ligand-induced lysis.
Rogers AM; Thilenius AR; Russell JH
J Immunol; 1997 Oct; 159(7):3140-7. PubMed ID: 9317111
[TBL] [Abstract][Full Text] [Related]
34. IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions.
Boselli D; Losana G; Bernabei P; Bosisio D; Drysdale P; Kiessling R; Gaston JS; Lammas D; Casanova JL; Kumararatne DS; Novelli F
Eur J Immunol; 2007 Aug; 37(8):2196-204. PubMed ID: 17595676
[TBL] [Abstract][Full Text] [Related]
35. Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.
Daniel PT; Oettinger U; Mapara MY; Bommert K; Bargou R; Dörken B
Eur J Immunol; 1997 Apr; 27(4):1029-34. PubMed ID: 9130660
[TBL] [Abstract][Full Text] [Related]
36. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
Winter H; Hu HM; Urba WJ; Fox BA
J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
[TBL] [Abstract][Full Text] [Related]
37. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.
Telford WG; Nam SY; Podack ER; Miller RA
Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701
[TBL] [Abstract][Full Text] [Related]
38. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
[TBL] [Abstract][Full Text] [Related]
39. Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
Jørgensen A; Wiencke AK; la Cour M; Kaestel CG; Madsen HO; Hamann S; Lui GM; Scherfig E; Prause JU; Svejgaard A; Odum N; Nissen MH; Röpke C
Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1590-9. PubMed ID: 9699548
[TBL] [Abstract][Full Text] [Related]
40. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
